Home> Products> uncontrolled diabetes

{ "products": [ { "_id": "68134d097702eb2332e5ccb0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLICLAGLAZE 40", "description": "GLICLAGLAZE 40 is an oral antidiabetic medication containing Gliclazide 40 mg, formulated to effectively manage Type 2 Diabetes Mellitus. It belongs to the class of drugs known as sulfonylureas, which are specifically designed to control blood glucose levels in adults who cannot manage diabetes through diet and exercise alone. By promoting insulin secretion and improving glycemic control, GLICLAGLAZE 40 helps prevent long-term complications associated with uncontrolled diabetes, such as nerve damage, kidney issues, and cardiovascular diseases.\n\nKey Ingredient\nGliclazide (40 mg):\nGliclazide is a second-generation sulfonylurea, known for its dual effect: stimulating insulin release from the pancreas and offering antioxidant properties. It not only lowers blood sugar but also provides vascular protection, making it suitable for patients at risk of cardiovascular events.\n\nKey Benefits\nEffectively reduces high blood sugar levels in Type 2 diabetes\n\nStimulates natural insulin secretion from pancreatic beta cells\n\nProvides cardiovascular protection by improving endothelial function\n\nMinimizes the risk of microvascular complications like retinopathy and nephropathy\n\nSuitable for long-term glycemic control when lifestyle measures are insufficient\n\nHelps maintain a stable glucose profile throughout the day\n\nHow Does It Work?\nGLICLAGLAZE 40 works by targeting the pancreas to enhance the secretion of insulin, which is essential for lowering blood glucose levels. Gliclazide binds to specific receptors on pancreatic beta cells, triggering the release of insulin in a glucose-dependent manner. This ensures that the medication works primarily when glucose levels are elevated, thus reducing the risk of hypoglycemia compared to older sulfonylureas. Additionally, its antioxidant properties contribute to improved vascular health, protecting blood vessels from oxidative damage often seen in diabetic patients.\n\nDirections for Use\nTake GLICLAGLAZE 40 exactly as prescribed by your healthcare provider\n\nUsually taken once or twice daily, preferably before meals\n\nSwallow the tablet whole with water — do not crush or chew\n\nMaintain a regular schedule for meals and medication to avoid hypoglycemia\n\nMonitor blood glucose levels regularly to track progress\n\nAlways combine with a balanced diet and exercise plan for optimal results\n\nSide Effects\nThough generally well-tolerated, GLICLAGLAZE 40 may cause some side effects:\n\nCommon Side Effects:\n\nHypoglycemia (low blood sugar)\n\nHeadache\n\nDizziness or light-headedness\n\nNausea or stomach discomfort\n\nWeight gain (in some patients)\n\nRare but Serious Side Effects:\n\nLiver enzyme abnormalities\n\nSkin rash or allergic reaction\n\nBlood disorders like anemia or thrombocytopenia\n\nVisual disturbances (usually temporary)\n\nSeek immediate medical attention if symptoms of severe hypoglycemia, such as confusion, fainting, or seizures, occur.", "price": 120.0, "discountamount": 34.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "gliclaglaze 40", "exercise plan", "balanced diet", "meals swallow", "nephropathy suitable", "gliclaglaze 40gliclaglaze 40", "seizures occur", "confusion fainting", "severe hypoglycemia", "medical attention", "temporary seek", "patients rare", "lightheadedness nausea", "track progress", "regular schedule", "daily preferably", "healthcare provider", "oxidative damage", "hypoglycemia compared", "glucosedependent manner", "specific receptors", "lifestyle measures", "microvascular complications", "secondgeneration sulfonylurea", "uncontrolled diabetes", "manage diabetes", "specifically designed", "chew maintain", "glucose levels", "cardiovascular protection", "promoting insulin secretion", "diabetic patients directions", "older sulfonylureas additionally", "medication works primarily", "oral antidiabetic medication", "stable glucose profile", "insufficient helps maintain", "vascular protection making", "thrombocytopenia visual disturbances", "antioxidant properties contribute", "longterm glycemic control", "pancreatic beta cells", "lowers blood sugar", "offering antioxidant properties" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2099, "imageuri": "https://productimages.withfloats.com/actual/68134d0b4b698d44a8c316f4.png", "tileimageuri": "https://productimages.withfloats.com/tile/68134d0b4b698d44a8c316f4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-01T10:29:29.141Z", "updatedon": "2025-05-01T10:29:29.141Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gliclaglaze-40/2099", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Gliclazide 40 mg", "category": "DIABETIC RANGE", "tags": [ "Gliclazide 40 mg uses in Hindi", "Gliclazide 40mg brands", "Gliclazide 40 mg price", "Gliclazide 40mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "679210353a716d60002bbd5a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Ramipril (2.5mg), Hydrochlorothiazide (12.5mg)", "description": "REMINIL H 2.5 / 12.5 is a combination medication formulated to manage high blood pressure effectively. It combines the benefits of Ramipril (2.5mg), an angiotensin-converting enzyme (ACE) inhibitor, and Hydrochlorothiazide (12.5mg), a thiazide diuretic. This dual-action formula works synergistically to lower blood pressure, reduce the risk of heart-related complications, and support overall cardiovascular health.\n\nThis medication is ideal for individuals needing a comprehensive approach to hypertension management. Regular use of REMINIL H 2.5 / 12.5 can help prevent strokes, heart attacks, and kidney problems associated with uncontrolled blood pressure.\n\n \n\nKey Benefits\n \n\nEfficient Blood Pressure Control: The combination of Ramipril and Hydrochlorothiazide effectively lowers high blood pressure, reducing the risk of severe complications like strokes and heart attacks.\nDual-Action Formula: Works by relaxing blood vessels and reducing excess fluid, ensuring comprehensive hypertension management.\nHeart Protection: Helps protect the heart by reducing the workload, improving blood flow, and minimizing the risk of heart failure.\nKidney Support: Particularly beneficial for people with diabetes or early-stage kidney issues, as it helps to protect kidney function.\nEdema Reduction: Reduces fluid retention and swelling in the body, ensuring better overall health.\n \nHow Does It Work?\n \n\nREMINIL H 2.5 / 12.5 combines two powerful mechanisms:\n\nRamipril inhibits the enzyme responsible for narrowing blood vessels, leading to their relaxation and improved blood flow. This reduces the pressure in the arteries and makes it easier for the heart to pump blood.\nHydrochlorothiazide increases urine output by removing excess salt and water from the body. This action reduces the volume of fluid in blood vessels, contributing to lower blood pressure.\nTogether, these ingredients work synergistically to ensure effective blood pressure control and cardiovascular protection.\n\n \nDirections for Use\n \n\nDosage: Take REMINIL H 2.5 / 12.5 as prescribed by your healthcare provider, usually once daily.\nTiming: Take the tablet at the same time every day, preferably in the morning to avoid frequent nighttime urination.\nWith or Without Food: This medication can be taken with or without food, as per your convenience.\nConsistency: Follow your doctor’s instructions for optimal results. Do not skip doses or stop taking the medication without consulting your doctor.\n \nSide Effects\n \n\nWhile REMINIL H 2.5 / 12.5 is generally well-tolerated, some individuals may experience mild side effects, including:\n\nDizziness or lightheadedness, especially when standing up quickly.\nIncreased frequency of urination (due to the diuretic effect).\nFatigue or weakness.\nDry cough (a common side effect of Ramipril).\nNausea or upset stomach.\nElectrolyte imbalances (low potassium or sodium levels).\nIf you experience severe side effects such as persistent coughing, swelling, difficulty breathing, or allergic reactions, seek immediate medical attention.", "price": 134.0, "discountamount": 41.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "25 125", "25 125 combines", "action reduces", "body ensuring", "individuals needing", "ramipril nausea", "ramipril 25mg", "work reminil", "medical attention", "sodium levels", "urination due", "generally welltolerated", "stop taking", "skip doses", "optimal results", "doctors instructions", "day preferably", "daily timing", "healthcare provider", "enzyme responsible", "severe complications", "comprehensive approach", "cardiovascular health", "heartrelated complications", "hydrochlorothiazide 125mg", "kidney problems", "thiazide diuretic", "combination medication formulated", "lower blood pressure", "diuretic effect fatigue", "cardiovascular protection directions", "ingredients work synergistically", "earlystage kidney issues", "allergic reactions seek", "common side effect", "weakness dry cough", "quickly increased frequency", "doctor side effects", "convenience consistency follow", "blood vessels contributing", "removing excess salt", "improved blood flow", "relaxing blood vessels", "hypertension management regular" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2036, "imageuri": "https://productimages.withfloats.com/actual/67921070802f20e1132aafe3.png", "tileimageuri": "https://productimages.withfloats.com/tile/67921070802f20e1132aafe3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-01-23T09:47:33.342Z", "updatedon": "2025-01-23T09:48:30.992Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ramipril-2-5mg-hydrochlorothiazide-12-5mg-/2036", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "REMINIL H 2.5 / 12.5 ", "category": "NEUROLOGY", "tags": [ "Ramipril 2.5 Hydrochlorothiazide 12.5 mg", "ramipril hydrochlorothiazide 5/25", "Ramipril and Hydrochlorothiazide tablets Uses in Hindi", "Ramipril H 5 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67122bef263d0316fb4c9dcb", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Gliclazide IP (40 mg) , Pioglitazone Hydrochloride IP (15 mg) , Metformin Hydrochloride IP (500 mg)", "description": "TRI-GLICLAGLAZE 40 is a powerful oral anti-diabetic medication formulated to manage Type 2 Diabetes Mellitus effectively. This combination of three potent drugs—Gliclazide, Pioglitazone, and Metformin—works synergistically to control high blood sugar levels, improve insulin sensitivity, and help patients achieve better glycemic control. TRI-GLICLAGLAZE 40 is designed for patients who struggle to manage blood glucose levels with single medications or lifestyle changes alone. It is a comprehensive solution for long-term diabetes management and reducing the risk of complications related to uncontrolled blood sugar.\n\n \n\nKey Benefits:\n \n\nEffective Blood Sugar Control: TRI-GLICLAGLAZE 40 helps maintain optimal blood glucose levels by targeting different aspects of diabetes management, such as stimulating insulin release, improving insulin sensitivity, and reducing glucose production.\nReduces Insulin Resistance: Pioglitazone and Metformin work together to lower insulin resistance, making it easier for the body to use insulin effectively.\nImproves Long-Term Glycemic Control: By combining three active ingredients, this medication is particularly beneficial for those struggling with glycemic control through diet or monotherapy alone.\nReduces Risk of Diabetes Complications: Controlling blood sugar levels helps prevent diabetes-related complications such as nerve damage, kidney disease, and cardiovascular problems.\nSupports Weight Management: Metformin, in particular, has been known to assist with weight management, which is important for patients with Type 2 Diabetes.\n \n\nHow Does It Work?\n \nTRI-GLICLAGLAZE 40 works through a multi-faceted mechanism to lower blood glucose levels:\n\nGliclazide stimulates the beta cells in the pancreas to release more insulin, which lowers blood sugar levels post-meal.\n\nPioglitazone enhances the body's sensitivity to insulin by promoting glucose uptake in the muscle and fat cells while also decreasing glucose production in the liver.\n\nMetformin reduces the production of glucose in the liver and improves insulin sensitivity. It also decreases the absorption of sugar from the intestines, ensuring better blood sugar control throughout the day.\n\nThis combination of ingredients targets multiple pathways involved in glucose regulation, making it an effective option for individuals with Type 2 Diabetes who require more comprehensive blood sugar control.\n\n \n\nDirections for Use:\n \nTake TRI-GLICLAGLAZE 40 exactly as prescribed by your doctor.\nUsually, it is taken once or twice daily with meals to minimize gastrointestinal discomfort.\nSwallow the tablet whole with water—do not crush or chew the tablet.\nContinue following your diet and exercise plan alongside the medication to achieve optimal blood sugar control.\nDo not skip doses, and consult your healthcare provider if you miss a dose.\n \n\nSide Effects:\n \nLike any medication, TRI-GLICLAGLAZE 40 may cause side effects, although not everyone experiences them. Some common and mild side effects include:\n\nHypoglycemia (Low Blood Sugar): Due to Gliclazide’s insulin-stimulating properties, low blood sugar may occur, especially if meals are skipped or exercise is excessive.\n\nGastrointestinal Issues: Metformin is known to cause digestive problems in some individuals, including nausea, vomiting, diarrhea, or stomach cramps.\n\nWeight Gain: Pioglitazone may cause weight gain in some users due to increased fat storage.\n\nFluid Retention: Pioglitazone may lead to water retention, especially in patients with heart conditions, increasing the risk of heart failure.\n\nHeadache and dizziness: These may occur as the body adjusts to the medication, but they are generally mild and temporary.\n\nLactic Acidosis (rare): A serious but rare side effect of Metformin, this condition requires immediate medical attention and is characterized by muscle pain, breathing difficulties, and weakness.\n\n ", "price": 145.0, "discountamount": 43.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "fat cells", "beta cells", "muscle pain", "fat storage", "Weight Gain", "nerve damage", "Key Benefits", "exercise plan", "Gliclazide IP", "heart failure", "stomach cramps", "kidney disease", "glucose uptake", "water retention", "insulin release", "Lactic Acidosis", "Fluid Retention", "Low Blood Sugar", "heart conditions", "rare side effect", "multiple pathways", "different aspects", "lifestyle changes", "Weight Management", "mild side effects", "Insulin Resistance", "digestive problems", "single medications", "glucose production", "glucose regulation", "three potent drugs", "insulin sensitivity", "healthcare provider", "breathing difficulties", "Diabetes Complications", "comprehensive solution", "Metformin Hydrochloride", "Gastrointestinal Issues", "multi-faceted mechanism", "cardiovascular problems", "high blood sugar levels", "Type 2 Diabetes Mellitus", "three active ingredients", "uncontrolled blood sugar", "Long-Term Glycemic Control", "gastrointestinal discomfort", "immediate medical attention", "optimal blood sugar control", "optimal blood glucose levels", "Pioglitazone Hydrochloride IP", "long-term diabetes management", "Effective Blood Sugar Control", "diabetes-related complications", "insulin-stimulating properties", "comprehensive blood sugar control", "powerful oral anti-diabetic medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1994, "imageuri": "https://productimages.withfloats.com/actual/67122bf4ac30f07ce03345d7.png", "tileimageuri": "https://productimages.withfloats.com/tile/67122bf4ac30f07ce03345d7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-10-18T09:35:43.008Z", "updatedon": "2024-10-18T09:35:43.008Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gliclazide-ip-40-mg-pioglitazone-hydrochloride-ip-15-mg-metformin-hydrochloride-ip-500-mg-/1994", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRI - GLICLAGLAZE 40 ", "category": "DIABETIC RANGE", "tags": [ "gliclazide+metformin hydrochloride tablets uses", "Gliclazide Metformin Pioglitazone brand name", "Gliclazide and Metformin hydrochloride tablets Use", "Gliclazide and Metformin Hydrochloride tablets pri", "Gliclazide and Metformin Hydrochloride Tablets bra", "Gliclazide 80 mg and Metformin Hydrochloride table", "", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665ef0928da3a81d5c69e509", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIBIMIDE 5 ", "description": "GLIBIMIDE 5 \nGlibenclamide (5 mg)\nGLIBIMIDE 5 is a medication containing Glibenclamide as its active ingredient, with each tablet containing 5 mg of the compound. Glibenclamide, also known as glyburide, belongs to the class of sulfonylurea medications and is commonly prescribed for the management of type 2 diabetes mellitus.\n\nAs a sulfonylurea, Glibenclamide works by stimulating the release of insulin from the pancreatic beta cells, thereby increasing insulin secretion. This mechanism of action helps to lower blood glucose levels by facilitating the uptake of glucose into cells for energy production and by reducing the production of glucose in the liver.\n\nGLIBIMIDE 5 is indicated for the treatment of type 2 diabetes mellitus in adults, particularly for patients whose blood sugar levels are not adequately controlled through lifestyle modifications alone. It is often prescribed as an adjunct to diet and exercise to improve glycemic control and prevent complications associated with uncontrolled diabetes.\n\nThe dosage of GLIBIMIDE 5 may vary depending on individual patient response and other factors such as age, renal function, and concurrent medications. It is typically administered orally once daily with breakfast or as directed by a healthcare professional.\n\nLike any medication, GLIBIMIDE 5 may cause side effects, including hypoglycemia (low blood sugar), gastrointestinal disturbances such as nausea or stomach upset, and allergic reactions in rare cases. Patients should be advised to monitor their blood sugar levels regularly and report any unusual symptoms to their healthcare provider.\n\nOverall, GLIBIMIDE 5 offers an effective option for the management of type 2 diabetes mellitus, providing patients with a convenient and reliable means of controlling their blood sugar levels. However, it should only be used under the guidance of a healthcare professional and as part of a comprehensive treatment plan that includes lifestyle modifications and regular monitoring of blood glucose levels.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glibimide-5-133417\n\n\n", "price": 12.22, "discountamount": 3.66, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "5 mg", "diet", "part", "liver", "class", "EMAIL", "Order", "uptake", "adults", "dosage", "tablet", "nausea", "adjunct", "release", "compound", "exercise", "patients", "guidance", "GLIBIMIDE", "mechanism", "breakfast", "glyburide", "management", "rare cases", "convenient", "information", "side effects", "hypoglycemia", "sterispharma", "sterisonline", "CALL/WHATSAPP", "complications", "Glibenclamide", "other factors", "stomach upset", "renal function", "reliable means", "low blood sugar", "effective option", "glycemic control", "unusual symptoms", "active ingredient", "energy production", "insulin secretion", "allergic reactions", "regular monitoring", "blood sugar levels", "healthcare provider", "blood glucose levels", "uncontrolled diabetes", "pancreatic beta cells", "concurrent medications", "lifestyle modifications", "healthcare professional", "type 2 diabetes mellitus", "sulfonylurea medications", "individual patient response", "comprehensive treatment plan", "gastrointestinal disturbances" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1283, "imageuri": "https://productimages.withfloats.com/actual/665ef0944f159c14e15f2960.png", "tileimageuri": "https://productimages.withfloats.com/tile/665ef0944f159c14e15f2960.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T10:46:42.559Z", "updatedon": "2024-06-04T10:46:42.559Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glibimide-5-/1283", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIBIMIDE 5 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665ed10e8da3a81d5c69dece", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DAPA VILDA 5/100 SR ", "description": "DAPA VILDA 5/100 SR \nDapagliflozin (5mg), Vildagliptin SR (100mg)\nDAPA VILDA 5/100 SR is a combination medication consisting of two active ingredients: Dapagliflozin (5mg) and Vildagliptin SR (100mg). Dapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor, while Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor with sustained-release formulation.\n\nDapagliflozin works by inhibiting SGLT2 in the kidneys, thereby reducing glucose reabsorption and increasing urinary glucose excretion, leading to lower blood glucose levels. Vildagliptin, on the other hand, acts by inhibiting DPP-4 enzyme, which prolongs the action of incretin hormones like GLP-1 and GIP, enhancing insulin secretion and suppressing glucagon release, ultimately reducing blood glucose levels.\n\nThis combination medication is indicated for the management of type 2 diabetes mellitus in adults. By targeting different pathways involved in glucose metabolism, DAPA VILDA 5/100 SR offers a comprehensive approach to glycemic control, helping patients achieve and maintain target blood glucose levels. It is typically prescribed as an adjunct to diet and exercise in patients whose diabetes is not adequately controlled with monotherapy or as a dual therapy option for those who require additional glucose-lowering agents.\n\nAs with any medication, DAPA VILDA 5/100 SR may cause side effects, including but not limited to urinary tract infections, genital mycotic infections, hypoglycemia, and gastrointestinal disturbances. Patients should be monitored regularly for these adverse effects, and dosage adjustments may be necessary based on individual response and tolerability.\n\nOverall, DAPA VILDA 5/100 SR offers a convenient once-daily dosing option and a synergistic approach to managing type 2 diabetes, helping patients achieve better glycemic control and potentially reducing the risk of long-term complications associated with uncontrolled diabetes. However, it should only be used under the supervision of a healthcare professional and as part of a comprehensive diabetes management plan tailored to the individual patient's needs and goals.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/dapa-vilda-5-100-sr-134362", "price": 130.0, "discountamount": 39.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "diet", "risk", "part", "EMAIL", "goals", "needs", "Order", "GLP-1", "adults", "action", "target", "adjunct", "kidneys", "patients", "exercise", "other hand", "dapa-vilda", "convenient", "monotherapy", "information", "supervision", "hypoglycemia", "DPP-4 enzyme", "sterispharma", "side effects", "tolerability", "sterisonline", "CALL/WHATSAPP", "transporter 2", "Dapagliflozin", "sodium-glucose", "Vildagliptin SR", "adverse effects", "SGLT2) inhibitor", "glycemic control", "glucagon release", "DPP-4) inhibitor", "insulin secretion", "incretin hormones", "dosage adjustments", "individual patient", "different pathways", "glucose metabolism", "DAPA VILDA 5/100 SR", "individual response", "dual therapy option", "daily dosing option", "synergistic approach", "glucose reabsorption", "uncontrolled diabetes", "two active ingredients", "dipeptidyl peptidase-4", "comprehensive approach", "combination medication", "healthcare professional", "long-term complications", "urinary tract infections", "type 2 diabetes mellitus", "urinary glucose excretion", "genital mycotic infections", "lower blood glucose levels", "sustained-release formulation", "gastrointestinal disturbances", "additional glucose-lowering agents", "comprehensive diabetes management plan" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1274, "imageuri": "https://productimages.withfloats.com/actual/665ed12ffb1d1538612033fd.png", "tileimageuri": "https://productimages.withfloats.com/tile/665ed12ffb1d1538612033fd.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T08:32:14.71Z", "updatedon": "2024-06-04T08:32:14.71Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/dapa-vilda-5-100-sr-/1274", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DAPA VILDA 5/100 SR ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68e7a474f3481c1f16d3b038", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin (50mg), Metformin Hydrochloride (500mg) & Glimepiride (2mg)", "description": "Sitagliptin 50mg, Metformin Hydrochloride 500mg & Glimepiride 2mg is a combination oral medication designed for the effective management of type 2 diabetes mellitus. This triple-action formula works synergistically to control blood glucose levels by addressing insulin resistance, enhancing insulin secretion, and regulating post-meal sugar spikes. Ideal for patients who require more than one mechanism to maintain stable blood sugar, this combination is often prescribed when monotherapy or dual therapy is insufficient.\n\nUses\n\nManagement of Type 2 Diabetes Mellitus in adults.\n\nHelps in controlling fasting and postprandial blood glucose levels.\n\nRecommended for patients whose blood sugar is not adequately controlled with a single antidiabetic medicine.\n\nCan be used as part of a comprehensive diabetes management plan, including diet and exercise.\n\nKey Benefits\n\nDual Mechanism Control:\n\nMetformin Hydrochloride reduces hepatic glucose production and improves insulin sensitivity.\n\nGlimepiride stimulates pancreatic beta cells to secrete more insulin.\n\nSitagliptin enhances incretin hormones, leading to better regulation of post-meal glucose levels.\n\nEffective Blood Sugar Management:\nHelps maintain optimal fasting and postprandial glucose levels, reducing the risk of diabetes-related complications.\n\nConvenient Combination Therapy:\nCombines three mechanisms in a single tablet, reducing the pill burden and improving patient compliance.\n\nSupports Overall Health:\nHelps prevent long-term complications such as neuropathy, nephropathy, retinopathy, and cardiovascular risks associated with diabetes.\n\nPossible Side Effects\n\nWhile generally well-tolerated, some patients may experience:\n\nGastrointestinal issues: nausea, vomiting, diarrhea, or abdominal discomfort (mainly from Metformin).\n\nHypoglycemia (low blood sugar): more likely due to Glimepiride; symptoms include dizziness, sweating, or shakiness.\n\nAllergic reactions: rash, itching, or swelling in rare cases.\n\nOther mild effects: headache, fatigue, or minor changes in taste.\n\nNote: Patients should always consult their doctor before starting this combination and report any unusual symptoms immediately.\n\nConclusion\n\nThe Sitagliptin, Metformin Hydrochloride & Glimepiride combination provides a powerful, multi-targeted approach to managing type 2 diabetes. By tackling high blood sugar from different angles, it supports better glucose control, enhances overall quality of life, and reduces the risk of diabetes-related complications. When used alongside proper diet, exercise, and medical guidance, this combination can be a cornerstone in effective diabetes management.", "price": 180.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2185, "imageuri": "https://productimages.withfloats.com/actual/68e7a47b040520d37b5e6b34.png", "tileimageuri": "https://productimages.withfloats.com/tile/68e7a47b040520d37b5e6b34.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-09T12:03:00.012Z", "updatedon": "2025-10-09T12:03:00.012Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sitagliptin-50mg-metformin-hydrochloride-500mg-glimepiride-2mg-/2185", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN GM", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2025-10-02T11:20:20.402Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68b02b8ff27bc023db27903e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DULOXTIME 60", "description": "DULOXTIME 60 contains Duloxetine 60 mg, designed in gastro-resistant tablet form to ensure smooth absorption in the intestine while reducing stomach irritation. Duloxetine is classified under serotonin and norepinephrine reuptake inhibitors (SNRIs), a group of medicines that help balance key brain chemicals—serotonin and norepinephrine. These neurotransmitters play a crucial role in regulating mood, emotional stability, pain perception, and nerve signaling.\n\nUses of DULOXTIME 60\n\nDULOXTIME 60 is a multipurpose therapy widely prescribed for both mental health conditions and pain-related disorders:\n\nMajor Depressive Disorder (MDD): Elevates mood, restores energy, and enhances quality of life in patients with depression.\n\nGeneralized Anxiety Disorder (GAD): Helps reduce constant worry, nervousness, and related physical symptoms such as restlessness and palpitations.\n\nDiabetic Peripheral Neuropathy: Relieves nerve pain, burning, and tingling sensations linked to diabetes.\n\nFibromyalgia: Eases widespread musculoskeletal pain and fatigue associated with fibromyalgia.\n\nChronic Musculoskeletal Pain: Effective for long-term pain conditions such as chronic back pain and osteoarthritis.\n\nSide Effects of DULOXTIME 60\n\nThough well-tolerated by most, some individuals may experience side effects:\n\nCommon Side Effects:\n\nNausea or constipation\n\nDry mouth\n\nDizziness, fatigue, or sleepiness\n\nIncreased sweating\n\nReduced appetite\n\nLess Common but Serious Side Effects:\n\nSevere mood changes or suicidal thoughts (particularly in younger patients)\n\nLiver problems (jaundice, abdominal pain, dark urine)\n\nRapid heartbeat or high blood pressure\n\nAllergic reactions such as swelling, rash, or itching\n\nSeek immediate medical help if severe side effects occur.\n\nPrecautions Before Taking DULOXTIME 60\n\nMental Health Monitoring: Patients with depression or anxiety should be closely observed for any worsening of symptoms or suicidal tendencies.\n\nLiver and Kidney Disorders: Should be avoided in those with severe liver or kidney disease.\n\nBlood Pressure & Heart: Regular monitoring is recommended as Duloxetine may raise blood pressure or alter heart rate.\n\nAlcohol Consumption: Avoid alcohol to reduce the risk of liver damage.\n\nPregnancy & Breastfeeding: Use only if prescribed by a doctor.\n\nDriving & Alertness: May cause dizziness or sleepiness; avoid driving or heavy machinery until you know how it affects you.\n\nDrug Interactions of DULOXTIME 60\n\nOther Antidepressants (SSRIs, MAOIs): May cause serotonin syndrome, a potentially serious condition.\n\nPainkillers (NSAIDs, Aspirin, Blood Thinners): Higher risk of bleeding.\n\nAlcohol or Liver-Toxic Drugs: Can increase chances of liver injury.\n\nStimulants: May worsen anxiety or palpitations.\n\nCertain Antibiotics/Antifungals: Can alter Duloxetine levels in the body.\n\nConclusion\n\nDULOXTIME 60 (Duloxetine Gastro-Resistant Tablets IP 60 mg) is a well-established and trusted option for managing depression, anxiety, nerve pain, fibromyalgia, and chronic musculoskeletal pain. By stabilizing brain chemicals and reducing pain signals, it not only improves emotional health but also provides physical relief, ensuring a better overall quality of life for patients.", "price": 368.0, "discountamount": 110.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2169, "imageuri": "https://productimages.withfloats.com/actual/68b02b92c670a5043ed545f2.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b02b92c670a5043ed545f2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-28T10:12:31.244Z", "updatedon": "2025-08-28T10:22:44.825Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/duloxtime-60/2169", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Duloxetine 60 mg Tablet", "category": "NEUROLOGY RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68b0256b813270ffac595cb0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRELAQWK 100", "description": "TRELAQWK 100 is an advanced oral antidiabetic medication containing Trelagliptin 100 mg, specifically designed for adults with type 2 diabetes mellitus (T2DM). Belonging to the class of Dipeptidyl Peptidase-4 (DPP-4) inhibitors, this formulation helps improve blood glucose control when used along with a proper diet and regular exercise.\nWith its once-weekly dosage regimen, TRELAQWK 100 offers a convenient treatment option, enhancing patient compliance and simplifying long-term diabetes management.\nKey Ingredient\nTrelagliptin 100 mg\nA long-acting DPP-4 inhibitor that regulates blood glucose levels by enhancing incretin hormones. These incretins stimulate insulin secretion and suppress glucagon release, helping to achieve better glycemic control.\nKey Benefits of TRELAQWK 100\nWeekly dosing ensures greater convenience and adherence\nReduces both fasting and postprandial blood sugar levels\nSupports natural blood sugar regulation without weight gain\nLow risk of hypoglycemia, especially when used as monotherapy or with non-insulin therapies\nCan be prescribed as monotherapy or in combination with other antidiabetic agents like metformin or sulfonylureas\nHow TRELAQWK 100 Works\nTRELAQWK 100 functions by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).\nThese incretin hormones:\nStimulate insulin secretion in response to meals\nReduce glucagon release, lowering blood sugar levels\nThanks to its extended half-life, trelagliptin allows for once-weekly dosing, unlike other DPP-4 inhibitors that require daily administration.\nDirections for Use\nDosage: Take one tablet of TRELAQWK 100 once weekly, or as directed by your physician\nAdministration: May be taken with or without food, ideally on the same day each week\nMissed dose: Do not double the dose; consult your healthcare provider for guidance\nPossible Side Effects\nTRELAQWK 100 is usually well-tolerated, but some individuals may experience:\nMild headache\nNasopharyngitis (common cold-like symptoms)\nConstipation\nUpper respiratory tract infections\nRare skin allergies (rash, itching)\n👉 If you experience persistent abdominal pain, severe rashes, or symptoms suggestive of pancreatitis, stop the medication and seek medical care immediately.", "price": 550.0, "discountamount": 165.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2166, "imageuri": "https://productimages.withfloats.com/actual/68b0256ebb42c3d551ad314c.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b0256ebb42c3d551ad314c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-28T09:46:19.602Z", "updatedon": "2025-08-28T09:46:19.602Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-100/2166", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "trelagliptin 100 mg", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }